Patents Represented by Attorney Panelli Haag PLLC
  • Patent number: 8148560
    Abstract: The present invention is directed to vaginal tablets comprising misoprostol and a pharmaceutically acceptable pH insensitive, hydrophilic cellulose material, wherein the vaginal tablets do not contain a hydrophobic release controlling agent, and wherein the misoprostol and the pharmaceutically acceptable pH insensitive, hydrophilic cellulose material are in a ratio of about 1:50 to about 1:800, and wherein the vaginal tablets do not substantially change the pH of a vaginal tract.
    Type: Grant
    Filed: September 25, 2006
    Date of Patent: April 3, 2012
    Assignee: Teva Women's Health, Inc.
    Inventors: Salah U. Ahmed, Raj R. Mahajan